Role of the Non-Receptor Tyrosine Kinase Fes in Cancer

By  

Current Medicinal Chemistry, Vol. 18, Iss. 19, 2011-06 ,pp. : 2913-2920

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting neurotrophin-3 and its dependence receptor tyrosine kinase receptor C: a new antitumoral strategy

By Tauszig-Delamasure Servane   Bouzas-Rodriguez Jimena  

Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 7, 2011-07 ,pp. : 847-858

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic targeting of receptor tyrosine kinases in lung cancer

By Choong Nicholas W   Ma Patrick C   Salgia Ravi  

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 3, 2005-06 ,pp. : 533-559

Informa Healthcare

Access to resources Recommend Favorite

Binding of gefitinib, an inhibitor of epidermal growth factor receptor-tyrosine kinase, to plasma proteins and blood cells: in vitro and in cancer patients

By Li Jing   Brahmer Julie   Messersmith Wells   Hidalgo Manuel   Baker Sharyn  

Investigational New Drugs, Vol. 24, Iss. 4, 2006-07 ,pp. : 291-297

Springer Publishing Company

Access to resources Recommend Favorite

The role of receptor tyrosine kinase inhibition in treating gastrointestinal malignancy

By Anderson MR   Jankowski JAZ  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 4, 2003-04 ,pp. : 577-592

Informa Healthcare

Access to resources Recommend Favorite